Circulation Genomic and Precision MedicineGarcía-Hernández et al.cohort
Does cumulative genetic burden (additional intermediate-effect variants or second monogenic variants) increase disease severity and major adverse cardiovascular events in MYBPC3 truncating variant carriers with hypertrophic cardiomyopathy?
Additional sarcomeric variants link to ~10.3-fold higher major cardiovascular events risk in MYBPC3tv carriers.
Hypothesis-generating for cumulative burden in MYBPC3 carriers; prospective validation needed before clinical adoption.

